Showing results (481-490 of 1,152) with videos related to

Sort By:
Pageof 116
Clinical Immunology (Orlando, Fla.)|April 15, 2008
Focus on FOCIS: interleukin 2 treatment associated autoimmunityStergios J Moschos, Maja Mandic, John M Kirkwood, et al.
Biochemical and Biophysical Research Communications|October 6, 2001
Mitochondrial lipid alterations during Fas- and radiation-induced apoptosisC M Matsko, O C Hunter, H Rabinowich, et al.
Zeitschrift Fur Kardiologie|May 31, 2001
[Leptin: a parameter for metabolic changes in heart failure]B M Richartz, U Lotze, A Krack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunityWentao Gao, Sanjay Kumar, Michael T Lotze, et al.
Archives of Gerontology and Geriatrics|February 24, 2009
Medical treatment of patients with atrial fibrillation aged over 80 years in daily clinical practice: influence of age and CHADS(2) scoreUlrich Lotze, Johannes Liebetrau, Ina Malsch, et al.
Annals of Nutrition & Metabolism|December 11, 1999
Measures of quality control in the German component of the EPIC study. European Prospective Investigation into Cancer and NutritionA Kroke, M M Bergmann, G Lotze, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 1, 2003
Comparison of representational maps using functional magnetic resonance imaging and transcranial magnetic stimulationM Lotze, R J Kaethner, M Erb, et al.
Blood|March 15, 1992
Effects of in vivo administration of interleukin-2 (IL-2) and IL-4, alone and in combination, on ex vivo human basophil histamine releaseM V White, Y Igarashi, B E Emery, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 1998
Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G0 to S phase transitionK Martincic, R Campbell, G Edwalds-Gilbert, et al.
The Journal of Gene Medicine|July 9, 2004
Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakinessSiamak Agha-Mohammadi, Mark O'Malley, Abrak Etemad, et al.
Pageof 116